paralyzed patients (i.e., rocuronium, cisatracurium) at the moment of enrollment patients under vasopressor therapy (i.e., norepinephrine, epinephrine, vasopressin) at the moment of enrollment patients expected to be discharged in the next 24 hours patient has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device. active wound infection below the knee amputations based on the clinicians decision whether the patient is eligible for the study

paralyzed patients (i.e., rocuronium, cisatracurium) at the moment of enrollment patients under vasopressor therapy (i.e., norepinephrine, epinephrine, vasopressin) at the moment of enrollment patients expected to be discharged in the next 24 hours patient has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device. active wound infection below the knee amputations based on the clinicians decision whether the patient is eligible for the study

- subject has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device. - active wound infection - below the knee amputations - based on the clinicians decision whether the patient is eligible for the study

- subject has a demand-type cardiac pacemaker, implanted defibrillator or other implanted electronic device. - active wound infection - below the knee amputations - based on the clinicians decision whether the patient is eligible for the study